Research graph
References from Editorial: Host Innate Immunity Reaches the Clinic—The Laboratory of Genetics and Physiology Protein 2 ( <scp>LGP2</scp> ) <scp>Q425R</scp> Variant and Severity of Chronic Hepatitis Delta. Local targets link to admitted publications; unresolved targets remain external evidence.
EASL Clinical Practice Guidelines on Hepatitis Delta Virus
10.1016/j.jhep.2023.05.001 · 2023 · External reference
Origin, HDV Genotype and Persistent Viremia Determine Outcome and Treatment Response in Patients With Chronic Hepatitis Delta
10.1016/j.jhep.2020.06.038 · 2020 · External reference
Effect of Variants in LGP2 on MDA5‐Mediated Activation of Interferon Response and Suppression of Hepatitis D Virus Replication
10.1016/j.jhep.2022.08.041 · 2023 · External reference
10.1111/apt.70971
10.1111/apt.70971 · External reference
Hepatitis D Virus‐Induced Interferon Response and Administered Interferons Control Cell Division‐Mediated Virus Spread
10.1016/j.jhep.2022.05.023 · 2022 · External reference
Hepatitis Delta Genotype 5 Is Associated With Favourable Disease Outcome and Better Response to Treatment Compared to Genotype 1
10.1016/j.jhep.2019.12.028 · 2020 · External reference
Bulevirtide Combined With Pegylated Interferon for Chronic Hepatitis D
10.1056/nejmoa2314134 · 2024 · External reference
Characteristics and Outcome of Anti‐Hepatitis D Virus Positive Patients With Hepatocellular Carcinoma
10.1111/liv.15855 · 2024 · External reference